...
首页> 外文期刊>Renal failure. >Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
【24h】

Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.

机译:慢性血液透析对胰岛素治疗的2型糖尿病患者的血糖控制和血脂的长期影响。

获取原文
获取原文并翻译 | 示例

摘要

There are only a few data in the literature concerning metabolic control in insulin-treated diabetic patients with end stage renal disease (ESRD). The aim of the study was to find out the long-term impact of hemodialysis on glycemic control and lipid values in type 2 diabetic patients. Twenty insulin-treated type 2 diabetic patients (age 62 +/- 9 years, f:m=6:14) were evaluated. We compared HbAlc, fasting blood glucose (FBG), body weight, serum lipids, insulin requirement, and blood-pressure (BP) 12 and 6 months before dialysis, at the start of dialysis, and 6 as well as 12 months after the start. RESULTS: The mean HbA1c- and FBG-values were not significantly different before and after the start of dialysis therapy. The average insulin requirement was 26 +/- 10 IU/day in the predialysis period, 25 +/- 12 IU/day at the start, and 24 +/- 13 as well as 22 +/- 13 IU/day after the start of dialysis. The mean cholesterol level fell significantly from 199 +/- 63 and 190 +/- 49 mg/dL in the predialysis phase to 167 +/- 62 and 157 +/- 38 mg/dL after dialysis began. The triglyceride concentrations decreased only slightly after the start of dialysis. The incidence of hypoglycemia (n/patient/month) was markedly lower in the predialysis phase (0.4 vs. 0.6, NS) than after start of dialysis. In patients with residual diuresis (<500 mL urine/day) the needed insulin doses decreased significantly by 29% compared to patients with higher residual diuresis, whose insulin requirement remained unchanged. In summary, hemodialysis had no significant long-term effect on glycemic control in insulin-treated type 2 diabetic patients, but incidence of hypoglycemia tended to be higher under hemodialysis than in the predialysis period. Lipid levels tended to be lower after the initiation of dialysis therapy. Insulin requirement under hemodialysis decreased only in patients with loss of residual urine volume (below 500 mL urine/day).
机译:文献中只有很少的数据涉及胰岛素治疗的患有终末期肾病(ESRD)的糖尿病患者的代谢控制。该研究的目的是找出血液透析对2型糖尿病患者血糖控制和血脂水平的长期影响。评估了20名接受胰岛素治疗的2型糖尿病患者(年龄62 +/- 9岁,f:m = 6:14)。我们比较了透析前,透析开始,透析开始后以及透析开始后12个月和6个月的HbAlc,空腹血糖(FBG),体重,血清脂质,胰岛素需求和血压(BP) 。结果:开始透析治疗前后,HbA1c和FBG的平均值无显着差异。透析前平均胰岛素需求量为26 +/- 10 IU /天,开始时为25 +/- 12 IU /天,开始后为24 +/- 13 IU和22 +/- 13 IU /天透析。平均胆固醇水平从透析前阶段的199 +/- 63和190 +/- 49 mg / dL显着下降到透析开始后的167 +/- 62和157 +/- 38 mg / dL。开始透析后,甘油三酸酯浓度仅略有下降。透析前阶段的低血糖发生率(n /患者/月)显着低于透析开始后(0.4 vs. 0.6,NS)。与具有较高残留尿量的患者(其胰岛素需求保持不变)相比,具有残留利尿的患者(<500 mL尿/天)所需的胰岛素剂量显着减少了29%。总之,在接受胰岛素治疗的2型糖尿病患者中,血液透析对血糖控制没有长期的显着影响,但是血液透析中低血糖的发生率往往比透析前高。开始透析治疗后,血脂水平趋于降低。血液透析中的胰岛素需求仅在残留尿量减少(低于500 mL尿/天)的患者中减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号